RESUMO
It has been claimed that glucosamine is able to alleviate pain, slow down losses of, and even restore articular cartilage in patients with damaged or osteoarthritic joints. It is classified as a food additive or nutraceutical; therefore manufacturers do not need to comply with the same regulations that apply for quality assurance within the pharmaceutical industry. Osteoarthritis can be managed by pharmacological and non-pharmacological methods. It is controversial whether glucosamine sulphate is the first structure-modifying drug commercially available. Little evidence suggests that glucosamine is superior to a placebo treatment in restoring articular cartilage.
Assuntos
Glucosamina/uso terapêutico , Osteoartrite do Joelho/tratamento farmacológico , Cartilagem Articular/efeitos dos fármacos , Glucosamina/química , Glucosamina/farmacologia , Humanos , Osteoartrite do Joelho/etiologia , Osteoartrite do Joelho/patologiaRESUMO
We report a rare case of simultaneous dorsal dislocation of 4 ulnar carpometacarpal joints and dorsoradial dislocation of the trapezium with an associated fracture of the scaphoid tuberosity. The injuries were diagnosed early and treated successfully with closed reduction and transfixation using Kirschner wires. The functional results were excellent at 17-month follow-up.
